AdvanCell Raises US$315 Million in Oversubscribed Series D Financing to Advance Lead-212 Targeted Alpha Therapy Platform AdvanCell, a clinical-stage radiopharmaceutical company focused on developing targeted alpha therapies for cancer, has…
Veradermics Reports Positive Phase 2 Results for Oral VDPHL01 in Female Pattern Hair Loss, Supporting Ongoing Pivotal Development Veradermics, Incorporated, a late-stage biopharmaceutical company focused on developing innovative therapies for…
Incyte Presents Positive Phase 1/2 Data for Latarcibart in Von Willebrand Disease, Supporting Ongoing Phase 3 Development Incyte has announced comprehensive safety and efficacy results from its Phase 1/2 multidose…
Infusion for Health Expands Home Infusion Services to Enhance Patient Access and Flexible Specialty Care Infusion for Health, a leading provider of specialty infusion therapy services, has announced the continued…
Meridian Bioscience Receives Health Canada Approval for Alethia® CMV Assay, Expanding Molecular Diagnostics Portfolio Meridian Bioscience, Inc., a global provider of diagnostic testing solutions and life science raw materials, has…
Revel Pharmaceuticals Publishes Nature Communications Study Demonstrating Enzyme That Reverses Age-Related Protein Damage Revel Pharmaceuticals has announced the publication of new research in Nature Communications describing a breakthrough enzyme capable…
Ionis and Biogen Report Positive Phase 2 Results for Diranersen in Early Alzheimer’s Disease, Supporting Advancement to Phase 3 Ionis Pharmaceuticals, Inc. has announced that its long-standing collaboration partner, Biogen,…
BioXcellerator Joins Congressional Veterans Care Forum to Advance Dialogue on Evidence-Based Regenerative Medicine BioXcellerator, a global provider of evidence-based regenerative medicine therapies, has announced that its Co-Founder and Chief Executive…
Hologic Expands CE-IVDR Approval for Aptima HPV Assay to Support Self-Collected Cervical Cancer Screening Samples Hologic, Inc. has announced that its Aptima® HPV Assay has received an expanded CE-IVDR marking…
OmniAb Appoints Amechi Nwachuku as Chief Operating Officer to Accelerate Growth of xPloration® Single B-Cell Screening Platform OmniAb, Inc., a biotechnology company recognized for its advanced antibody discovery technologies that…
Charles River Laboratories Partners with Arovella Therapeutics to Advance GMP Next-Generation Sequencing for CAR-iNKT Cell Therapy Development Charles River Laboratories International, Inc. has announced a strategic collaboration with Arovella Therapeutics…
CEL-SCI Launches Global Confirmatory Registration Study of Multikine® for Newly Diagnosed Head and Neck Cancer CEL-SCI Corporation has announced the initiation of its global Confirmatory Registration Study evaluating Multikine® (Leukocyte…